Supplier has advised Pharmac of a supply issue of the above-mentioned products. Click the below link to access Pharmac Website information https://www.pharmac.govt.nz/medicine-funding-and-supply/medicine-notices/ticagrelor Anticipated ETA– unknown.
Pharmac has awarded the Tender to an alternative brand which will be listed from 1 April 2026 and move to Principal Supply Status effective from
Rex Medical have advised Pharmac they can no longer supply this product into New Zealand. Stock is depleted. Pharmac listed from 1 June 2025 under
Pharmac have awarded the Tender to a new product listing 1 May 2026. Incumbent: Esbriet Tab 267mg 90, Pharmacode 2602156 (1169765), Schedule price $1215.00. Esbriet
Chiesi New Zealand Ltd have advised that supply has been reinstated. Click here to access the supplier notification. ProPharma should have stock of this product
Supplier has advised Pharmac of a supply issue of the above-mentioned products. Click the below link to access Pharmac Website information https://www.pharmac.govt.nz/medicine-funding-and-supply/medicine-notices/acarbose-2 Anticipated ETA– unknown.
Supplier has advised Pharmac of an impending supply issue of the above-mentioned product. Click here to read market notification. Anticipated ETA– unknown. ProPharma have stock
Supplier has advised Pharmac of an out-of-stock situation from late January 2026 Anticipated ETA– mid to late March 202, to be confirmed. Click the following
There is a global shortage of ADHD medicines, as well as significant increase in demand. Availability changes by the day. Click the following link to
Abbott Laboratories NZ Ltd have advised that there will be a change in fill weight of both flavours beginning in April 2026. Moving from 850g
Supplier has advised Pharmac of a supply issue of the above-mentioned products. Click the below link to access Pharmac Website information https://www.pharmac.govt.nz/medicine-funding-and-supply/medicine-notices/ticagrelor Anticipated ETA– unknown.
Pharmac has awarded the Tender to an alternative brand which will be listed from 1 April 2026 and move to Principal Supply Status effective from
Rex Medical have advised Pharmac they can no longer supply this product into New Zealand. Stock is depleted. Pharmac listed from 1 June 2025 under